KRAS and colorectal carcinoma: Compared to the mutation rate of KRAS, there are fewer studies focusing on the mutation rate of NRAS. The mutation rate of NRAS in CRC obtained in this study was in the midstream position compared to other reports (4, 6, 13, 14, 16).